Reply to: "Cell Therapy for Huntington's Disease: Learning from Failure"

Roger L Albin^{1

2

3

4}, Jeffrey H Kordower^{5

6}

Affiliations

¹ Neurology Service & GRECC, VAAAHS, Ann Arbor, Michigan, USA.
² Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
³ University of Michigan Parkinson's Foundation Research Center of Excellence, Ann Arbor, Michigan, USA.
⁴ Michigan Alzheimer Disease Center, Ann Arbor, Michigan, USA.
⁵ Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
⁶ Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.

Free article

Comment

Roger L Albin et al. Mov Disord. 2021 Mar.

Free article

. 2021 Mar;36(3):788-789.

doi: 10.1002/mds.28500.

Roger L Albin^{1

2

3

4}, Jeffrey H Kordower^{5

6}

¹ Neurology Service & GRECC, VAAAHS, Ann Arbor, Michigan, USA.
² Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
³ University of Michigan Parkinson's Foundation Research Center of Excellence, Ann Arbor, Michigan, USA.
⁴ Michigan Alzheimer Disease Center, Ann Arbor, Michigan, USA.
⁵ Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
⁶ Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.

No abstract available

Keywords: Huntington disease; cell therapy.

Comment on

A Failed Future.
Albin RL, Kordower JH. Albin RL, et al. Mov Disord. 2020 Aug;35(8):1299-1301. doi: 10.1002/mds.28130. Mov Disord. 2020. PMID: 32780511 No abstract available.
Cell Therapy for Huntington's Disease: Learning from Failure.
Rosser AE, Busse M, Aron Badin R, Canals JM, Wheelock V, Perrier AL, Gray W, Thompson L, Goldman S. Rosser AE, et al. Mov Disord. 2021 Mar;36(3):787-788. doi: 10.1002/mds.28503. Mov Disord. 2021. PMID: 33749919 Free PMC article. No abstract available.